Search Browse Earnings

OptimizeRx Corp

Nasdaq:OPRX

Services-Business Services, NEC·WALTHAM, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

OptimizeRx Corp — SlamSEC

Revenue

$4.5M

FY 2022

Adj. EBITDA

-$24.4M

-539.8% margin

FY 2024

Net Income

-$17.6M

-388.9% margin

FY 2024

EPS (Diluted)

-$1.03

FY 2024

Stock Price

$6.73

-10.5%

2026-03-06

52W Range

$3.99 – $22.25

P/E Ratio

-6.5x

Market Cap

$125.5M

Cash

$13.9M

FY 2024

Total Debt

$34.2M

FY 2024

Net Debt

$20.4M

FY 2024

Enterprise Value

$145.8M

Debt / EBITDA

-0.8x

FY 2022

EV / EBITDA

-6.0x

Employees

—

CEO

Silvestro Stephen L